Metis Global Partners’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Metis Global Partners's ELV Position: Q2 2026 in Review
Metis Global Partners reduced its Elevance Health (ELV) stake by 15% in Q2 2026, selling an estimated $470K and leaving 7,341 shares worth $2.84M. The position accounts for 0.06% of the portfolio, ranked #228.
Metis Global Partners first reported a position in ELV in Q4 2021 and has held it in 19 quarters since. The position peaked at $6.27M in Q3 2024. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Metis Global Partners held 7,341 shares of Elevance Health worth $2.84M as of Q2 2026.
- Metis Global Partners sold 1,268 Elevance Health shares in Q2 2026, an estimated $470K.
- Elevance Health made up 0.06% of Metis Global Partners's portfolio in Q2 2026, its #228 holding.
- Metis Global Partners first reported a position in Elevance Health in Q4 2021 and has held it in 19 quarters since.
- Metis Global Partners's Elevance Health position peaked at $6.27M in Q3 2024.
- 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Metis Global Partners's 13F filing for Q2 2026, filed 10 Aug 2026.